- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Invasive Mammary Carcinoma
A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
CLINICAL HISTORY
A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
FINDINGS
Digital mammography reveals an irregular 2.2cm mass in the left breast, approximately 10cm from the nipple (Figure 1a-b). The mass persists on the magnification view (Figure 1c).
(Figure 1a)
(Figure 1b)
(Figure 1c)
On physical exam, no discrete mass is palpated. Ultrasound demonstrates an irregular hypoechoic mass within the left 3:30 area measuring up to 1.4cm (Figure 2).
(Figure 2)
MRI imaging performed for extent of disease demonstrates the known carcinoma measuring 2.0 x 2.2cm in the left breast (Figure 3a-b).
(Figure 3a)
(Figure 3b)
DIAGNOSIS
Vacuum assisted stereotactic needle core biopsy of the left breast 3:30 mass reveals invasive mammary carcinoma.
DISCUSSION
This case demonstrates the benefit of screening mammography in a premenopausal woman. This was a large lesion that was not palpable and was not found by the patient or her physician. This was identified on the screening mammogram which initiated additional evaluation with magnification views, ultrasound, stereotactic biopsy, and subsequent breast MRI.
Stamatia Destounis, MD, is managing partner and a radiologist at Elizabeth Wende Breast Care in Rochester, NY.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
Study Emphasizes PSMA PET Staging of High-Risk, Hormone Sensitive Prostate Cancer
January 4th 2025In patients with high-risk, hormone sensitive prostate cancer who had no evidence of metastasis on conventional imaging, PSMA PET revealed polymetastatic disease in 24 percent of patients and M1 disease staging in 46 percent of patients.
Can MRI and Micro-Ultrasound Guidance Bolster Focal Laser Ablation Outcomes for Prostate Cancer?
January 3rd 2025For patients with localized prostate cancer and PI-RADS 3 or higher lesions, MRI-guided micro-ultrasound multifiber focal laser ablation had an 18 percent recurrence rate at one year, according to newly published research.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
